Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcast
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Epidemiology/Health Services/Psychosocial Research

Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance

  1. Akira Katsuki, MD1,
  2. Yasuhiro Sumida, MD1,
  3. Hideki Urakawa, MD1,
  4. Esteban C. Gabazza, MD1,
  5. Shuichi Murashima, MD2,
  6. Noriko Maruyama, MD1,
  7. Kohei Morioka, MD1,
  8. Kaname Nakatani, MD3,
  9. Yutaka Yano, MD1 and
  10. Yukihiko Adachi, MD1
  1. 1Third Department of Internal Medicine, Mie University School of Medicine, Mie, Japan
  2. 2Department of Radiology, Mie University School of Medicine, Mie, Japan
  3. 3Department of Laboratory Medicine, Mie University School of Medicine, Mie, Japan
  1. Address correspondence and reprint requests to Yasuhiro Sumida, MD, Third Department of Internal Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. E-mail: sumidaya{at}clin.medic.mie-u.ac.jp
Diabetes Care 2003 Aug; 26(8): 2341-2344. https://doi.org/10.2337/diacare.26.8.2341
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE—The purpose of this study was to investigate the association between visceral adiposity or triglyceride (TG) metabolism and insulin resistance in metabolically obese, normal weight (MONW) Japanese individuals with normal glucose tolerance.

RESEARCH DESIGN AND METHODS—We evaluated body fat areas, lipid profiles, and the glucose infusion rate (GIR) during a euglycemic-hyperinsulinemic clamp study in 20 MONW subjects (BMI <25 kg/m2and visceral fat areas 100 cm2) with normal glucose tolerance. Body fat areas were measured by computed tomography scans. Control data were obtained from 20 normal subjects (BMI <25 kg/m2 and visceral fat areas <100 cm2).

RESULTS—MONW subjects showed a significant increase in fasting serum levels of TG (P < 0.01) and a decrease in GIR (P < 0.01) compared with normal subjects. There were significant correlations between visceral fat areas (r = −0.563, P < 0.01) or serum levels of TG (r = −0.474, P < 0.05) and GIR in MONW subjects. Multiple regression analyses showed that visceral fat areas (F = 7.702, P < 0.02) and serum levels of TG (F = 7.114, P < 0.05) were significantly associated with GIR in all (MONW and normal) subjects.

CONCLUSIONS—Increased visceral fat and serum levels of TG are associated with insulin resistance in Japanese MONW subjects with normal glucose tolerance. Excess visceral fat and elevated TG levels may play important roles in the development of insulin resistance in Japanese MONW subjects with normal glucose tolerance.

  • AUC, area under the curve
  • GIR, glucose infusion rate
  • MONW, metabolically obese, normal weight
  • TG, triglyceride

Recent reports described the existence of individuals with normal body weight but with a cluster of obesity-related characteristics (1,2). They are characterized by excess visceral fat, insulin resistance, and hyperinsulinemia and have been called metabolically obese, normal weight (MONW) subjects. Ethnic differences should be considered for identifying MONW subjects. In the Japanese population, nonobese (BMI <25 kg/m2) subjects with increased visceral fat areas (100 cm2) fulfill the criteria for categorizing them in the MONW group (2–6). Regarding the association of the MONW state with diabetes, higher prevalence of hyperglycemia has been observed in MONW subjects than in normal individuals (3,4).

Previous studies have demonstrated that visceral fat areas are associated with insulin resistance in Japanese subjects with normal glucose tolerance and impaired glucose tolerance and in nonobese Japanese patients with type 2 diabetes (7–9). Visceral fat accumulation is also associated with serum triglyceride (TG) levels, and the disturbance of TG metabolism precedes the development of insulin resistance in nonobese Japanese type 2 diabetic patients (9,10). However, the relationships of visceral adiposity and TG metabolism with insulin resistance in Japanese MONW subjects with normal glucose tolerance have not been evaluated. To clarify these points, in the present study, we investigated the relationship between visceral fat areas or serum levels of TG and insulin resistance in Japanese MONW subjects with normal glucose tolerance.

RESEARCH DESIGN AND METHODS

Subjects

This study comprised 20 MONW and 20 age-matched normal subjects (BMI <25 kg/m2 and visceral fat areas <100 cm2). BMI was calculated as body weight (in kilograms) divided by the square of height (in meters).

None of the subjects had impaired glucose tolerance or diabetes according to the diagnostic criteria of the American Diabetes Association based on the 75-g oral glucose tolerance test (Trelan G 75; Shimizu, Shimizu, Japan) (11). Eleven subjects in the MONW group had hyperlipidemia (total cholesterol 5.69 mmol/l or TG 1.69 mmol/l). Arterial hypertension was not observed in any subject. None of the subjects were receiving any medication that could affect insulin levels and insulin sensitivity, and the subjects were not under any regular exercise or dietary therapy before the beginning of this study. Three normal and five MONW subjects had a family history of diabetes among their first-degree relatives. We asked all subjects whether some member of their family had obesity (BMI 25 kg/m2) or had a past history of obesity. One normal and two MONW individuals had a family history of obesity among their first-degree relatives.

Informed consent was obtained from all subjects before the beginning of the study.

Methods

Several parameters in blood samples, body fat weight, body fat distribution, insulin resistance, the capacity to secrete insulin, and blood pressure were evaluated in all subjects. Venous blood was collected at 8:00 a.m. after an overnight bed rest. After centrifugation, the plasma and serum samples were separated in small aliquots and then frozen at −20°C until use.

The plasma glucose level was measured by an automated enzymatic method. Serum levels of total cholesterol, TG, HDL cholesterol, and free fatty acids were measured by enzymatic methods using an autoanalyzer (TBA60M; Toshiba, Tokyo, Japan). Serum insulin levels were measured using an immunoradiometric assay kit (Insulin Riabead II kit; Dainabot, Tokyo, Japan). This kit included 125I-labeled and unlabeled anti-human insulin mouse monoclonal antibodies. The intra- and interassay coefficients of variation of the assay were 1.9% and 2.0%, respectively. No cross-reactivity or interference was observed between insulin and proinsulin, C-peptide, glucagon, secretin, and gastrin-I.

Body fat weight was measured by bioelectric impedance using a TBF-101 (Tanita, Tokyo, Japan). Body fat area was evaluated by a previously described method (5,6,12). At 8:00 a.m., after an overnight fast of 11 h, all subjects underwent a single abdominal-computed tomography scan at the umbilical level. Any intraperitoneal region having the same density as the subcutaneous fat layer was defined as a visceral fat area; this area was measured by tracing object contours on film using a computerized planimetric method.

Insulin resistance was evaluated by the euglycemic-hyperinsulinemic clamp technique using an artificial pancreas (Nikkiso STG-22; Nikkiso, Tokyo, Japan) (5,6,13). At 8:00 a.m., a priming dose of insulin (Humulin R; Shionogi, Osaka, Japan) was administered during the initial 10 min in a logarithmically decreasing manner to rapidly raise serum insulin to the desired level (1,200 pmol/l); this level was then maintained by continuous infusion of insulin at a rate of 13.44 pmol · kg−1 · min−1 for 120 min. The mean insulin level, from 90 to 120 min after starting the clamp study, was stable (MONW subjects, 1,235.4 ± 52.2 pmol/l; normal subjects, 1,187.4 ± 46.8 pmol/l). Blood glucose was monitored continuously and maintained at the target clamp level (5.24 mmol/l) by infusing 10% glucose. The mean amount of glucose given during the last 30 min was defined as the glucose infusion rate (GIR) and was used as a measure of peripheral insulin sensitivity.

The 75-g oral glucose tolerance test was started at 8:00 a.m. after an overnight bed rest (fasting for 11 h). Blood was taken at 0, 30, 60, and 120 min, and plasma glucose and serum insulin were evaluated. The capacity to secrete insulin in response to oral glucose stimulation was estimated by the ratio of I30 to G30 (I30/G30 was calculated as follows: increment of serum insulin from 0 to 30 min/increment of plasma glucose from 0 to 30 min) and the insulin area under the curve (AUC). Plasma glucose AUC was also calculated. We also measured blood pressure in supine position after a 5-min rest.

Statistical analysis

Comparisons between MONW and normal subjects were done using the two-tailed Student’s t test. Correlations were evaluated by univariate regression analysis and multivariate analysis. All statistical analyses were performed using the StatView 4.0 software (Abacus Concepts, Berkeley, CA) for the Macintosh. P < 0.05 was considered statistically significant.

RESULTS

BMI (P < 0.01), body fat weight (P < 0.01), visceral (P < 0.01) and subcutaneous fat areas (P < 0.01), and systolic (P < 0.01) and diastolic blood pressure (P < 0.01) were significantly increased in MONW subjects compared with normal subjects (Table 1).

MONW individuals showed significant hyperinsulinemia and hypertriglyceridemia (fasting insulin levels, P < 0.01; insulin AUC, P < 0.05; TG, P < 0.01) compared with normal subjects. The GIR in MONW subjects were significantly decreased compared with normal subjects (P < 0.01).

There were significant correlations between visceral fat areas (r = −0.563, P < 0.01) (Fig. 1) or serum levels of TG (r = −0.474, P < 0.05) (Fig. 2) and GIR in MONW subjects. Visceral fat areas were significantly correlated with serum levels of TG (r = 0.533, P < 0.02) and fasting serum levels of insulin (r = 0.503, P < 0.05) in MONW subjects.

No significant correlations were observed between subcutaneous (r = −0.249, P = 0.290) or total (visceral and subcutaneous) fat areas (r = −0.366, P = 0.113) and GIR in MONW subjects.

Multiple regression analyses showed that visceral fat areas (F = 7.702, P < 0.02) and serum levels of TG (F = 7.114, P < 0.05) were significantly associated with GIR in all (MONW and normal) subjects.

CONCLUSIONS

This is the first report that demonstrates a significant relationship of increased visceral fat or elevated serum TG levels with insulin resistance in Japanese MONW subjects with normal glucose tolerance.

Recent studies have demonstrated that visceral rather than subcutaneous adipose tissue secrete adipocytokines and that their circulating levels are correlated with the development of insulin resistance and with the occurrence of cardiovascular diseases (4,14–18). Visceral fat accumulation may be a major contributor for the development of insulin resistance in Japanese MONW subjects with normal glucose tolerance. The MONW state can be diagnosed in subjects at a young age (2); therefore, it is necessary to diagnose this syndrome early to prevent the occurrence of several obesity-related disorders. Scoring methods should be proposed for identifying MONW subjects in the Japanese population as well as in other ethnic groups (2).

The explanation for the significant correlation between serum levels of TG and insulin resistance in Japanese MONW subjects with normal glucose tolerance remains unknown. Normalization of TG metabolism through surgical procedures has been reported to improve insulin resistance in two sisters with extreme hypertriglyceridemia due to familial lipoprotein lipase deficiency (19). Our MONW subjects showed minimally elevated serum levels of TG. Mild but not severe hypertriglyceridemia may lead to insulin resistance in Japanese MONW subjects with normal glucose tolerance.

Diet combined with exercise therapy is useful to reduce visceral fat and improve insulin resistance in nonobese patients with type 2 diabetes (5,6). It has been reported that improvement of TG metabolism by bezafibrate reduces insulin resistance in nonobese Japanese patients with type 2 diabetes (20). Bezafibrate with diet and exercise therapy may be indicated in MONW subjects with normal glucose tolerance to prevent the development of glucose intolerance.

In the present study, a significant relationship between visceral fat areas and serum TG levels was observed in Japanese MONW subjects with normal glucose tolerance. Taniguchi et al. (9) reported the same relationship in nonobese Japanese type 2 diabetic patients. It was reported that free fatty acids released from intraperitoneal fat tissue is drained directly into the liver through the portal system, leading to increased serum TG levels (21). This may also occur in Japanese MONW subjects with normal glucose tolerance. Thus, it is conceivable that visceral fat accumulation is the primary factor for the development of insulin resistance in Japanese MONW subjects with normal glucose tolerance.

In conclusion, the present study showed that increased visceral fat and serum levels of TG are associated with insulin resistance in Japanese MONW subjects with normal glucose tolerance. Excess visceral fat and elevated TG levels may play important roles in the development of insulin resistance in nonobese Japanese subjects with and without type 2 diabetes.

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

Correlation between visceral fat areas and GIR in Japanese MONW subjects with normal glucose tolerance. Visceral fat areas were significantly correlated with GIR (r = −0.563, P < 0.01).

Figure 2—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2—

Correlation between serum levels of TG and GIR in Japanese MONW subjects with normal glucose tolerance. Serum levels of TG were significantly correlated with GIR (r = −0.474, P < 0.05).

View this table:
  • View inline
  • View popup
Table 1—

Clinical characteristics of the study subjects

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted April 24, 2003.
    • Received March 27, 2003.
  • DIABETES CARE

References

  1. ↵
    Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (Review). Diabetologia 46: 3–19, 2003
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited. Diabetes 47: 699–713, 1998
    OpenUrlAbstract
  3. ↵
    The Examination Committee of Criteria for “Obesity Disease” in Japan, Japan Society for the Study of Obesity: New criteria for “obesity disease” in Japan. Circ J 66: 987–992, 2002
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Matsuzawa Y: Pathophysiology and molecular mechanism of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13: 1–13, 1997
    OpenUrlPubMed
  5. ↵
    Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, Kitagawa N, Takashi T, Araki-Sasaki R, Hori Y, Nakatani K, Yano Y, Adachi Y: QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 87: 2906–2908, 2002
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y: Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24: 362–365, 2001
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Nagaretani H, Nakamura T, Funahashi T, Kotani K, Miyanaga M, Tokunaga K, Takahashi M, Nishizawa H, Kishida K, Kuriyama H, Hotta K, Yamashita S, Matsuzawa Y: Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 24: 2127–2133, 2001
    OpenUrlAbstract/FREE Full Text
  8. Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hayashi M, Nishitani K, Hamanaka D, Nakaishi S, Kamamoto T, Nagata I, Okumura T, Kishimoto H, Fukushima M: Relationship of regional adiposity to insulin resistance in nonobese Japanese type 2 diabetic patients (Letter). Diabetes Care 24: 966–968, 2001
    OpenUrlFREE Full Text
  9. ↵
    Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamaoka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M: Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism 51: 544–548, 2002
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y: Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23: 1766–1769, 2000
    OpenUrlAbstract/FREE Full Text
  11. ↵
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 10: 1183–1197, 1997
    OpenUrl
  12. ↵
    Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S: A novel technique for the determination of body fat by computed tomography. Int J Obes 7: 437–445, 1983
    OpenUrlPubMedWeb of Science
  13. ↵
    DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–E223, 1979
  14. ↵
    Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409–2415, 1995
  15. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-α (TNF-α) are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83: 859–862, 1998
    OpenUrlCrossRefPubMedWeb of Science
  16. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221: 286–289, 1996
    OpenUrlCrossRefPubMedWeb of Science
  17. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni RA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930–1935, 2001
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2: 1–5, 1996
  19. ↵
    Mingrone G, Henriksen FL, Greco AV, Krogh LN, Capristo E, Gastaldelli A, Castagneto M, Ferrannini E, Gasbarrini G, Beck-Nielsen H: Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes 48: 1258–1263, 1999
    OpenUrlAbstract
  20. ↵
    Fukushima M, Taniguchi A, Sakai M, Doi K, Nagata I, Nagasaka S, Tokuyama K, Nakai Y: Effect of bezafibrate on insulin sensitivity in nonobese Japanese type 2 diabetic patients (Letter). Diabetes Care 23: 259, 2000
    OpenUrl
  21. ↵
    Wajchenberg BL: Sucutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697–738, 2000
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Diabetes Care: 26 (8)

In this Issue

August 2003, 26(8)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
Citation Tools
Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance
Akira Katsuki, Yasuhiro Sumida, Hideki Urakawa, Esteban C. Gabazza, Shuichi Murashima, Noriko Maruyama, Kohei Morioka, Kaname Nakatani, Yutaka Yano, Yukihiko Adachi
Diabetes Care Aug 2003, 26 (8) 2341-2344; DOI: 10.2337/diacare.26.8.2341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance
Akira Katsuki, Yasuhiro Sumida, Hideki Urakawa, Esteban C. Gabazza, Shuichi Murashima, Noriko Maruyama, Kohei Morioka, Kaname Nakatani, Yutaka Yano, Yukihiko Adachi
Diabetes Care Aug 2003, 26 (8) 2341-2344; DOI: 10.2337/diacare.26.8.2341
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suboptimal Use of Cardioprotective Drugs in Newly Treated Elderly Individuals With Type 2 Diabetes
  • Disparities in Diabetes Care Between Smokers and Nonsmokers
  • Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women
Show more Epidemiology/Health Services/Psychosocial Research

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • BMJ Open - Diabetes Research & Care
  • Standards of Medical Care in Diabetes
  • Scientific Sessions Abstracts
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2019 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.